PAB
PATRYS Ltd
- Announcements, last 12 months
- 64
- Price sensitive, last 12 months
- 26
- Followed on InvestorPA
- Low (Outside the 20% most-followed companies on InvestorPA)
Latest announcements
| Released | Headline | Actions |
|---|---|---|
| RLS-2202 Phase 1a Trial Advances to Cohort 2 Price sensitive | ||
| Investor Presentation Price sensitive | ||
| Investor Webinar Price sensitive | ||
| Date of AGM and Closing Date for Director Nominations | ||
| Notification of cessation of securities - PAB | ||
| Patrys Completes Cohort 1 Dosing and Follow-Up Price sensitive | ||
| Appendix 4E Variance Report Price sensitive | ||
| Annual Report - 30 June 2025 | ||
| Appendix 4G and Corporate Governance Statement | ||
| First Participants Dosed in RLS-2202 Phase 1A Clinical Trial Price sensitive |
Sign in to see all PAB announcements.
Most followed in Health Care
Follow PAB to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in